On World Mental Health Day, we reflect on the strides being made in mental health care and the hope that new therapies bring. A recent breakthrough—a safer treatment for agitation in schizophrenia and bipolar disorders—embodies this progress. CRC is proud to have supported the clinical trials that led to FDA approval, staying true to our mission of improving patients’ lives.
Transforming Patient Care Through Collaboration
This new therapy offers a safer, more compassionate way to manage agitation, giving patients and healthcare providers more control in critical moments. The approval underscores the power of teamwork and dedication. Micah Humphrey, one of the many contributors to the project’s success, shared his excitement for this important milestone.
A Lasting Commitment to Global Mental Health
With nearly 970 million people worldwide affected by mental health conditions, CRC is honored to have supported 15 FDA-approved CNS treatments. On this World Mental Health Day, we thank all those working tirelessly to improve mental health. Our shared commitment to advancing life-changing therapies continues to drive us forward.
Need Support
200 Central Ave, Ste. 1200
St. Petersburg, Florida 33701
Stay Connected with CRC
Join our newsletter to stay connected with the world of CRC. From case studies and scientific papers to networking opportunities.